RMC-7977RMC-7977 - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-156498-01.804-HY-156498-01804-HY-156498-01Business & Industrial > Science & LaboratoryRMC-7977
Gentaur
EUR12027-02-21

RMC-7977

CAT:
804-HY-156498-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
RMC-7977 - image 1

RMC-7977

  • Description:

    RMC-7977 is an orally active triple-complex RAS inhibitor that can simultaneously bind to cyclophilin A (CYPA) (Kd = 195 nM) and KRAS (G12V) (Kd = 292 μM) . It exhibits broad-spectrum inhibitory activity against KRAS, NRAS, and HRAS proteins and their various wild-type and mutant variants. RMC-7977 induces apoptosis by inhibiting the phosphorylation of ERK, CRAF, and RSK, as well as increasing PARP cleavage. This leads to tumor regression, reduces resistance in KRASG12C cancer models, and demonstrates good tolerability across various RAS cancer models[1][2][3].
  • UNSPSC:

    12352005
  • Target:

    AMPK; Apoptosis; ERK; PARP; Raf; Ras; Ribosomal S6 Kinase (RSK)
  • Type:

    Reference compound
  • Related Pathways:

    Apoptosis; Cell Cycle/DNA Damage; Epigenetics; GPCR/G Protein; MAPK/ERK Pathway; PI3K/Akt/mTOR; Stem Cell/Wnt
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/rmc-7977.html
  • Concentration:

    10mM
  • Purity:

    99.48
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    CO[C@H](C1=[C@@](C=C(N2CCN(C3CC3)CC2)C=N1)[C@@](N4CC)=C(C5=C4C=CC6=C5)CC(C)(C)COC([C@@H](N7)CCCN7C([C@@H](NC([C@@H]8[C@@H]9[C@H]8COC9)=O)CC%10=NC6=CS%10)=O)=O)C
  • Molecular Formula:

    C47H60N8O6S
  • Molecular Weight:

    865.11
  • References & Citations:

    [1]Singh M, et al. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy. Research Square; 2023.|[2]Popescu B, et al. RAS MULTI (ON) inhibitor RMC-7977 targets oncogenic RAS mutations and overcomes RAS/MAPK-mediated resistance to FLT3 inhibitors in AML models[J]. Blood, 2023, 142: 2793.|[3]Wasko UN, et al. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature. 2024 May;629 (8013) :927-936.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Isoform:

    C-Raf; H-Ras; K-Ras; N-Ras
  • CAS Number:

    [2765082-12-8]